Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1: A Randomized Controlled Trial
JAMA 300:287-294, Krab,L.C.,et al., 2008
Optic Pathway Gliomas in Neurofibromatosis-1: Controversies and Recommendations
Ann Neurol 61:189-198, Listernick,R.,et al, 2007
Fragile X Premutation With Atypical Symptoms at Onset
Arch Neurol 63:1135-1138, Cellini,E.,et al, 2006
Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005
Clinicopath Conf, Neurofibromatosis Type 1, with Multiple Spinal Neurofibromas
NEJM 352:1800-1808, Case 13-2005, 2005
Initial Diagnoses Given to Persons with the Fragile X Associated Tremor/Ataxia Syndrome (FXTAS)
Neurol 65:299-301, Hall,D.A.,et al, 2005
Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
JAMA 291:460-469, Jacquemont,S.,et al, 2004
Homestatic Factors as Risk Markers for Intracerebral Hemorrhage
Stroke 35:826-830, Johansson, L.,et al, 2004
Diagnostic Approach in Patients with Symmetric Imaging Lesions of the Deep Gray Nuclei
The Neurologist 9:250-261, Finelli,P.F.&DiMario,Jr,F.J., 2003
Von Recklinghausen's Neurofibromatosis: Neurofibromatosis Type 1
Lancet 361:1552-1554, Reynolds,R.M., et al, 2003
Encephalitis lethargica syndrome:20 new cases and evidence of basal ganglia autoimmunity
Brain 127, 21-33, Dale, R.C., et al, 2003
Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction.
AJNR 23:1757-1766, Brunberg,J.A.,et al, 2002
The DYT1 Phenotype and Guidelines for Diagnostic Testing
Neurol 54:1746-1753,1718, Bressman,S.B.,et al, 2000
Radiation-Induced Cerebral Vasculopathy in Children with Neurofibromatosis and Optic Pathway Glioma
Ann Neurol 45:393-396, Grill,J.,et al, 1999
What Level of Care for the Neurofibromatoses?
Lancet 353:1114-1116, Huson,S.M., 1999
Hyperintense Basal Ganglia on T1-Weighted MR Imaging
AJR 172:1109-1115, Lai,P.H.,et al, 1999
Neurological Complications of Neurofibromatosis Type 1 in Adulthood
Brain 122:473-481, Creange,A.,et al, 1999
Signs and Symptoms of Duchenne Muscular Dystrophny and Becker Muscular Dystrophy Among Carriers in the Netherlands: A Cohort Study
Lancet 353:2116-2119, Hoogerwaard,E.M.,et al, 1999
Bilateral Substantia Nigra Changes on MRI in a Patient with Encephalitis Lethargica
Neurol 53:1860-1862, Kun,L.N.,et al, 1999
Magnetic Resonance Imaging Lesion Analysis in Neurofibromatosis Type 1
Arch Neurol 55:500-505, DiMario,F.J.&Ramsby,G., 1998
Neurofibromatosis:An Unusual Cause of Cervical Myopathy
J Spine Cord Med 21:148-150, Barber,D.B.,et al, 1998
Von Willebrand Factor and Risk of Ischemic Stroke
Neurol 49:1552-1556, Qizilbash,N.,et al, 1997
X Linked Adrenoleukodystrophy:Clinical Presentation, Diagnosis, and Therapy
JNNP 63:4-14, vanGeel,B.M.,et al, 1997
X-Linked Emery-Dreifuss Muscular Dystrophy Can Be Diagnosed from Skin Biopsy or Blood Sample
Ann Neurol 42:249-253, Mora,M.,et al, 1997
Precocious Puberty in Two Children with Neurofibromatosis Type I in the Absence of Optic Chiasmal Glioma
J Pediatr 130:155-157, Zacharin,M., 1997
Optic Pathway Gliomas in Children with Neurofibromatosis 1:Consensus Stmt NF1 Optic Pathway Glioma Task Force
Ann Neurol 41:143-149, Listernick,R.,et al, 1997
The Diagnostic Evaluation & Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
JAMA 278:51-57, Gutmann,D.H.,et al, 1997
Cognitive Function and Academic Performance in Neurofibromatosis 1:North
K. N. , et al, Neurol 48:1121-11277., , 1997
Evolution of High-Intensity Basal Ganglia Lesions on T1-Weighted MR in Neurofibramotisis Type 1
AJNR 17:755-760, Terada,H.A.,et al, 1996
The Management of Brainstem Gliomas in Patients with Neurofibromatosis 1
Neurol 46:1652-1660, Pollack,I.F.,et al, 1996
Development of Cardiomyopathy in Female Carriers of Duchenne and Becker Muscular Dystrophies
JAMA 275:1335-1338, Politano,L.,et al, 1996
Neurofibromatosis 1 and Multiple Sclerosis
JNNP 58:582-585, Ferner,R.E.,et al, 1995
Neurofibromatosis Type 1:Pathologic Substrate of High-Signal-Intensity Foci in the Brain
Radiology 195:721-724, DiPaolo,D.P.,et al, 1995
Rapid Antibody Test for Fragile X Syndrome
Lancet 345:1147-1148, Willemsen,R.,et al, 1995
Brainstem Tumors in Patients with Neurofibromatosis Type 1:A Distinct Clinical Entity
Neurol 45:1897-1902, Molloy,P.T.,et al, 1995
Neurofibroma Manifested by Spinal Subarachnoid Hemorrhage
AJR 162:959-960, Cummings,T.M.&Johnson,M.H., 1994
Cerebrovascular Abnormalities in Neurofibromatosis Type 1
Neurol 44:1000-1002, Rizzo,J.F.&Lessell,S., 1994
Neurofibromatosis Type 1:The Cognitive Phenotype
J Pediatr 124:S1-S8, Hofman,K.J.,et al, 1994
Specific Learning Disability in Children with Neurofibromatosis Type 1:Significance of MRI Abnormalities
Neurol 44:878-883, North,K.,et al, 1994
Rapid Direct Diagnosis of Deletions Carriers of Duchenne and Becker Muscular Dystrophies
Lancet 344:302-303, Fassati,A.,et al, 1994
Natural History of Optic Pathway Tumors in Children with Neurofibromatosis Type I:A Longitudinal Study
J Pediatr 125:63-66, Listernick,R.,et al, 1994
Skin Lesions of the Spinal Axis and Spinal Dysraphism:Fifteen Cases & Review of the Literature
Arch Pediatr Adolesc Med 148:740-748, McAtee-Smith,J.,et al, 1994
MRI of Transient Postencephalitic Parkinsonism
J Comput Assist Tomogr 18:155-159, Shen,W.,et al, 1994
Advances in Molecular Analysis of Fragile X Syndrome
552, Warren,W.T.&Nelson,D.L.JAMA 271:536-553, 1994
Gliomas of the Anterior Visual Pathway
Surv Ophthalmol 38:427-452, Dutton, J., 1994
Rapid Fragile X Carrier Screening and Prenatal Diagnosis Using a Nonradioactive PCR Test
JAMA 270:1569-1575, Brown,W.,et al, 1993
Comprehensive Study of Diagnosis and Treatment of Trigeminal Neuralgia Secondary to Tumors
Neurol 43:2298-2302, Cheng,T.M.W.,et al, 1993
Cardiomyopathy May Be the Only Clinical Manifestation in Female Carriers of Duchenne Muscular Dystrophy
Neurol 43:2342-2345, Mirabella,M.,et al, 1993
Sudden Death of a Carrier of X-Linked Emery-Dreifuss Muscular Dystrophy
Ann Int Med 119:900-905, Fishbein,M.C.,et al, 1993
Intradural Conus and Cauda Equina Tumours:A Retrospective Review of Presentation, Diagnosis & Early Outcome
JNNP 56:69-74, Mathew,P.&Todd,N.V., 1993